Detailed information for compound 1528965

Basic information

Technical information
  • TDR Targets ID: 1528965
  • Name: 7-(1-morpholin-4-yl-1-oxopropan-2-yl)oxy-4-ph enylchromen-2-one
  • MW: 379.406 | Formula: C22H21NO5
  • H donors: 0 H acceptors: 2 LogP: 2.61 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(C(Oc1ccc2c(c1)oc(=O)cc2c1ccccc1)C)N1CCOCC1
  • InChi: 1S/C22H21NO5/c1-15(22(25)23-9-11-26-12-10-23)27-17-7-8-18-19(16-5-3-2-4-6-16)14-21(24)28-20(18)13-17/h2-8,13-15H,9-12H2,1H3
  • InChiKey: MTPBCLYJBARWAA-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 7-(1-methyl-2-morpholino-2-oxo-ethoxy)-4-phenyl-chromen-2-one
  • 7-(1-methyl-2-morpholino-2-oxoethoxy)-4-phenyl-2-chromenone
  • 7-(2-keto-1-methyl-2-morpholino-ethoxy)-4-phenyl-coumarin
  • 7-(1-morpholin-4-yl-1-oxo-propan-2-yl)oxy-4-phenyl-chromen-2-one
  • T5510093

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glycoprotein hormones, alpha polypeptide Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Toxoplasma gondii intraflagellar transport protein 172, putative glycoprotein hormones, alpha polypeptide 116 aa 94 aa 26.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0129 0.7417 0.7417
Echinococcus multilocularis glutamate receptor 2 0.0129 0.7417 0.7417
Echinococcus granulosus glutamate receptor ionotrophic AMPA 3 0.0129 0.7417 0.7417
Brugia malayi Glutamate receptor 2 precursor 0.0109 0.3615 0.5
Echinococcus multilocularis nmda type glutamate receptor 0.0144 1 1
Echinococcus granulosus Glutamate receptor ionotropic kainate 2 0.0129 0.7417 0.7417
Schistosoma mansoni glutamate receptor NMDA 0.0129 0.7417 1
Echinococcus granulosus Glutamate receptor ionotropic kainate 2 0.0129 0.7417 0.7417
Loa Loa (eye worm) glutamate receptor 2 0.0109 0.3615 0.5
Brugia malayi Glutamate receptor 1 precursor 0.0109 0.3615 0.5
Loa Loa (eye worm) glutamate receptor 1 0.0109 0.3615 0.5
Treponema pallidum amino acid ABC transporter, periplasmic binding protein 0.0103 0.2583 0.5
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0129 0.7417 0.7417
Echinococcus multilocularis glutamate (NMDA) receptor subunit 0.0109 0.3615 0.3615
Echinococcus multilocularis glutamate receptor, ionotrophic, AMPA 3 0.0129 0.7417 0.7417
Echinococcus granulosus glutamate NMDA receptor subunit 0.0109 0.3615 0.3615
Chlamydia trachomatis glutamine binding protein 0.0103 0.2583 0.5
Echinococcus multilocularis glutamate receptor 2 0.0109 0.3615 0.3615
Echinococcus granulosus Glutamate receptor ionotropic kainate 2 0.0129 0.7417 0.7417
Mycobacterium tuberculosis Probable glutamine-binding lipoprotein GlnH (GLNBP) 0.0103 0.2583 0.5
Echinococcus granulosus glutamate receptor 2 0.0129 0.7417 0.7417
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 3 0.0144 1 1
Mycobacterium ulcerans glutamine-binding lipoprotein GlnH 0.0103 0.2583 0.5
Chlamydia trachomatis arginine ABC transporter substrate-binding protein ArtJ 0.0103 0.2583 0.5
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 2 0.0129 0.7417 0.7417
Treponema pallidum amino acid ABC transporter, periplasmic binding protein (hisJ) 0.0103 0.2583 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 11.2202 uM PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 25.1189 uM PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 29.0929 uM PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.